Most Recent
Briefly: Coles, REA, Nine among this week’s litigation targets
Business of Law 2026-05-29 11:56 pm By Cat Fredenburgh
Lawyers stuck inside by the dreary, cold weather have been keeping busy penning a slew of new suits targeting the likes of Coles, REA and Nine.
Biotech files new patent suit against Samsung Bioepis over Crohn’s drug
Intellectual Property 2024-09-26 11:55 pm By Sam Matthews Melbourne
Samsung Bioepis can't get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug. 
Samsung Bioepis sues Janssen Biotech to invalidate Stelara patents
Intellectual Property 2024-02-08 11:48 pm By Christine Caulfield
South Korean biosimilars company Samsung Bioepis has sued Johnson & Johnson's Janssen Biotech to invalidate two patents for Crohn's disease drug Stelara, after reaching a licencing agreement over the medicine in the US.